8 Reasons a Psychotropic Medication May Be Discontinued

Slideshow

Tips for having a balanced and comprehensive risk-to-benefit discussion with competent patients who want to stop their medications.

This article was originally posted on January 28, 2015 and has since been updated.

Related Videos
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
nicotine use
brain schizophrenia
schizophrenia
schizophrenia
exciting, brain
journey
Related Content
The study sheds light on the potential risks and adverse effects of polypharmacy in patients with complex psychiatric conditions.

Examining a Case of Psychiatric Polypharmacy-Related Agranulocytosis

May 17th 2024
Article
Treating ‘Morally Objectionable’ Patients

Treating ‘Morally Objectionable’ Patients

September 27th 2021
Podcast
Here’s a look at our recent coverage of these disorders in honor of Mother’s Day 2024.

Postpartum Depression and Psychosis in Psychiatric Times

May 12th 2024
Article
Blue Light, Depression, and Bipolar Disorder

Blue Light, Depression, and Bipolar Disorder

August 4th 2021
Podcast
What is new in research on stress and anxiety disorders?

Stress and Anxiety Disorders Research Roundup: May 10, 2024

May 10th 2024
Article
Gone in a puff of smoke? Researchers investigated the effectiveness of antipsychotics in reducing the risk of hospitalization in patients with first-episode psychosis and co-occurring CUD.

Antipsychotic Use and Psychiatric Hospitalization in First-Episode Psychosis and Cannabis Use Disorder

May 10th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.